News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,167 Results
Type
Article (42405)
Company Profile (294)
Press Release (673468)
Section
Business (210442)
Career Advice (2096)
Deals (36635)
Drug Delivery (106)
Drug Development (83040)
Employer Resources (175)
FDA (16559)
Job Trends (15401)
News (356028)
Policy (33900)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2592)
Accelerated approval (2)
Adcomms (21)
Allergies (84)
Alliances (51393)
ALS (87)
Alzheimer's disease (1374)
Antibody-drug conjugate (ADC) (116)
Approvals (16560)
Artificial intelligence (246)
Autoimmune disease (18)
Automation (14)
Bankruptcy (371)
Best Places to Work (11775)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (188)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (251)
Cancer (2039)
Cardiovascular disease (171)
Career advice (1753)
Career pathing (30)
CAR-T (141)
Cell therapy (401)
Cervical cancer (19)
Clinical research (67283)
Collaboration (786)
Compensation (460)
Complete response letters (25)
COVID-19 (2654)
CRISPR (41)
C-suite (217)
Cystic fibrosis (101)
Data (1977)
Decentralized trials (2)
Denatured (26)
Depression (41)
Diabetes (253)
Diagnostics (6418)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (115)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (86)
Earnings (87906)
Editorial (33)
Employer branding (21)
Employer resources (149)
Events (114571)
Executive appointments (662)
FDA (17689)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (698)
Gene editing (103)
Generative AI (20)
Gene therapy (293)
GLP-1 (725)
Government (4502)
Grass and pollen (4)
Guidances (48)
Healthcare (19002)
Huntington's disease (23)
IgA nephropathy (23)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2786)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (89)
Interviews (323)
IPO (16765)
IRA (47)
Job creations (4055)
Job search strategy (1495)
Kidney cancer (9)
Labor market (34)
Layoffs (476)
Leadership (16)
Legal (8373)
Liver cancer (71)
Lung cancer (294)
Lymphoma (136)
Machine learning (4)
Management (59)
Manufacturing (280)
MASH (63)
Medical device (13414)
Medtech (13419)
Mergers & acquisitions (20339)
Metabolic disorders (655)
Multiple sclerosis (70)
NASH (17)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1870)
NextGen: Class of 2025 (6644)
Non-profit (4525)
Northern California (2441)
Now hiring (37)
Obesity (354)
Opinion (226)
Ovarian cancer (73)
Pain (87)
Pancreatic cancer (77)
Parkinson's disease (135)
Partnered (20)
Patents (209)
Patient recruitment (94)
Peanut (49)
People (59095)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20866)
Phase II (29605)
Phase III (22196)
Pipeline (1052)
Podcasts (75)
Policy (125)
Postmarket research (2654)
Preclinical (8843)
Press Release (68)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (374)
Real estate (6254)
Recruiting (67)
Regulatory (23013)
Reports (46)
Research institute (2371)
Resumes & cover letters (359)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (72)
Series A (123)
Series B (79)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2116)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3725)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (47)
United States (21436)
Vaccines (677)
Venture capitalists (37)
Webinars (12)
Weight loss (242)
Women's health (33)
Worklife (15)
Date
Today (156)
Last 7 days (754)
Last 30 days (2845)
Last 365 days (34124)
2025 (8251)
2024 (35774)
2023 (40634)
2022 (51805)
2021 (56346)
2020 (54798)
2019 (47418)
2018 (35788)
2017 (33159)
2016 (32675)
2015 (38624)
2014 (32531)
2013 (27643)
2012 (29745)
2011 (30497)
2010 (28508)
Location
Africa (783)
Alabama (49)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (40609)
Australia (6507)
California (5573)
Canada (1883)
China (487)
Colorado (250)
Connecticut (257)
Delaware (131)
Europe (86592)
Florida (825)
Georgia (194)
Idaho (57)
Illinois (511)
India (24)
Indiana (299)
Iowa (9)
Japan (146)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (838)
Massachusetts (4236)
Michigan (211)
Minnesota (372)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1600)
New Mexico (29)
New York (1604)
North Carolina (941)
North Dakota (7)
Northern California (2441)
Ohio (191)
Oklahoma (14)
Oregon (38)
Pennsylvania (1266)
Puerto Rico (9)
Rhode Island (26)
South America (1162)
South Carolina (18)
South Dakota (1)
Southern California (2116)
Tennessee (93)
Texas (836)
Utah (166)
Virginia (138)
Washington D.C. (57)
Washington State (519)
West Virginia (3)
Wisconsin (51)
716,167 Results for "arena pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Obesity Late-Comer AbbVie Inks up to $2.2B Amylin Deal With Gubra
AbbVie is joining the amylin arena, though the pharma is still far behind leaders Novo Nordisk and Eli Lilly.
March 3, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
BMS’ Sotyktu Notches Phase III Win in Psoriatic Arthritis
In the plaque psoriasis arena, Sotyktu is facing off against Amgen’s Otezla and is facing the threat of upcoming competition from Alumis’ investigational TYK2 inhibitor.
March 10, 2025
·
2 min read
·
Tristan Manalac
Cancer
Arcus Challenges Merck in Kidney Cancer with Early Data
Casdatifan’s progression-free survival benefits could help differentiate it from Merck’s Welireg in the kidney cancer arena, according to analysts at Truist Securities.
February 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards
November 11, 2024
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
IgA nephropathy
Biogen, Vertex Heat Up IgAN Arena With Mid-Stage Readouts at ASN 2024
William Blair analyst Myles Minter in a Monday note to investors said that Vertex’s povetacicept “has maintained its potential to be a best-in-class asset” in the IgA nephropathy space and could become a “multibillion-dollar pipeline-in-a-drug product” for autoimmune disorders, while “outstanding questions” remain for Biogen’s felzartamab before moving into pivotal studies.
October 28, 2024
·
3 min read
·
Tristan Manalac
IPO
Metsera Seeks $289M Raise, $1.78B Valuation in IPO
The GLP-1 IPO arena has been heating up for the past two years and Metsera’s ask is one the largest in recent history.
January 27, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program
March 25, 2025
·
4 min read
Genetown
Arena BioWorks Launches as a Privately Funded, Fully Independent Biomedical Institute to Shorten the Path from Insight to Therapeutics
Arena BioWorks announced today its launch as a biomedical research institute with a mission to uncover mechanisms of disease by engaging in basic biological research that will be translated into lifesaving biotech therapeutics.
January 12, 2024
·
11 min read
Press Releases
Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
March 10, 2025
·
6 min read
1 of 71,617
Next